The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and ...
Around the world, events are being held to mark Rare Disease Day (28 February 2025), with the aim of bringing attention to rare diseases and improving access to diagnosis and therapies for patients.
To deliver treatments for rare diseases more quickly, companies share how they are adapting their launch strategies and ...
A study led by Queen Mary University of London has found 69 previously unidentified genetic determinants of rare diseases.
Just in time for Women’s History Month and International Women’s Day on March 8th, Medscape is proud to showcase its ...
Tired of the disconnect in virtual meetings? Discover how using webcams can enhance communication, build stronger relationships, and create a more engaging work environment.
Eli Lilly has unveiled plans to invest at least $27bn in building four new pharmaceutical manufacturing sites in the US.
Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody ...
The challenge for companies is to ensure their local affiliates meet local PV obligations while staying aligned with global PV requirements ...
Founded in 2004 and headquartered in New York, Synapse is the leading medical marketing and communications company, with the largest in-house team of medical professionals. Let us give your brand the ...
Amgen’s Blincyto (blinatumomab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat ...
The phase 3 SERENA-6 study randomised patients with HR-positive, HER2-negative advanced breast cancer whose tumours had an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results